Assess Impact of Poly-L-lactic Acid on GLP1 Subjects

Part of paid clinical trials in San Diego, California.

Sponsor
Goldman, Butterwick, Fitzpatrick and Groff
Study ID
NCT07217743
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Laxity; Skin

Eligibility Criteria

Sex
FEMALE
Age
25 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Sculptra Aesthetic — DEVICE
    15 GLP1 subjects treated with Sculptra to their abdomen for skin laxity will be compared to 5 non GLP1 subjects treated with Sculptra for skin laxity.

Study Details

Clinical trial to evaluate treatments of double-dilute poly-L-lactic acid on abdominal skin laxity in GLP1 patients versus non GLP1 patients.

Key Dates

Start date
Oct 27, 2025
Status verified
Oct 2025
Primary completion
Aug 30, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: GLP1 Patients
    15 Participants who have been on a stable dose of GLP1 for at least 6 months will receive three treatments, one month apart, of Sculptra Aesthetic up to 16cc.
  • Experimental: NON GLP1 Patients
    5 participants who are GLP1 naive will receive three treatments, one month apart, of Sculptra Aesthetic up to 16cc.

Primary Outcome Measure

Physical Global Aesthetic Improvement Scale [ Time Frame: Month 3 and Month 9 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Dermatology Research CenterSan DiegoCalifornia92121
Andrea Pacheco
858-657-1004
Freia Canals-Cistero
858-657-1004

Find similar trials in San Diego, CA

Related Studies